A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 262
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IC
Long Form : intracoronary
No. Year Title Co-occurring Abbreviation
2020 Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49). IQR, PPCI, TIMI
2019 A Continuous Intracoronary Versus A Standard Intravenous Infusion of Adenosine for Fractional Flow Reserve Assessment - the HYPEREMIC Trial. CI, FFR
2019 Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention. CK-MB, hs-TnT, LVEF, MACE, MBG, PCI, STEMI, TIMI
2019 Comparison of intracoronary versus intravenous adenosine-induced maximal hyperemia for fractional flow reserve measurement: A systematic review and meta-analysis. FFR
2019 Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells. CPC, LVEF, pCPC
2019 Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model. ATP, IMR
2019 Feasibility of right coronary artery first ergonovine provocation test. LCA, RCA
2019 Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes inWomen. CAD, CI, CR, HR, HR, MACE, WISE
2019 Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention. MBG, PCI, STEMI
10  2019 The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trial. CAD, CFI
11  2019 The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. CAD, CSF, TFC
12  2019 Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis. ATP, FFR, IVATP210
13  2018 A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis. CMR, PCI
14  2018 Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis. FFR
15  2018 Intracoronary Glycoprotein IIb/IIIa Inhibitors Improve Short-Term Mortality and Reinfarction in East Asian Patients with ST-Segment Elevation Myocardial Infarction after Thrombus Aspiration: A Meta-Analysis. CI, GPIs, LVEF, MACE, OR, PCI, STEMI, STR, TA, TIMI
16  2018 Intracoronary high-dose bolus tirofiban administration during complex coronary interventions: A United States-based case series. ACS, GPIs, HDB
17  2018 Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery. AMF, FGF-2, GFP, LVEF, MI, MMP-2, MSCs
18  2018 Perforated balloon technique: A simple and handy technique to combat no-reflow phenomenon in coronary system. ACS, PBT, PCI
19  2018 Simplifying the assessment of coronary artery stenosis by enhancing instantaneous wave free ratio. AUC, CAS, FFR, iFR, ROC
20  2017 An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. BMCs, G-CSF, IM
21  2017 Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD. CMD, CMRI, CPT, MPRI
22  2017 Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction-mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines With Acute Myocardial Infarction. Ang-1, IC-UTMD, IC-UTMD-Ang1, IV-UTMD, IV-UTMD-Ang1, MI
23  2017 Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. MVO, PPCI, SNP
24  2017 Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. CDCs, CMI, IM, IS, LVEF, MI, MRI
25  2017 Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5'-triphosphate infusion. ATP, FFR, NIC
26  2017 Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart. ---
27  2017 Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: case series and literature review. FFR
28  2017 Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials. ACS, CIs, cTFC, GPIs, IL, MACEs, OR, TIMI, WMD
29  2017 Meta-Analysis of Head-to-Head Comparison of Intracoronary Versus Intravenous Adenosine for the Assessment of Fractional Flow Reserve. CI, FFR
30  2017 Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. CI, MACE, RR
31  2017 Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury. CSC, IM
32  2017 Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. ACh, ERGO
33  2017 Temporal dissociation between the minimal distal-to-aortic pressure ratio and peak hyperemia during intravenous adenosine infusion. ---
34  2016 Appropriate bolus administration of glycoprotein IIb/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review. GP, HF, LVEF, re-MI, TVR
35  2016 Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction. cTFC, LVEF, MACEs, PPCI, STEMI, TIMI, TPG, TVR
36  2016 Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. PCI
37  2016 Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions. FFR
38  2016 Efficacy and Safety of Local Intracoronary Drug Delivery in Treatment of No-Reflow Phenomenon: A Pilot Study. MACEs, PCI, TIMI
39  2016 Efficacy of coronary fractional flow reserve using contrast medium compared to adenosine. CMR, FFR
40  2016 Impaired coronary artery distensibility is an endothelium-dependent process and is associated with vulnerable plaque composition. ACh, CAD, CDI, CFR, CSA, IVUS
41  2016 Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial. cTFC, MBG, PPCI, STEMI, STR
42  2016 Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment. ---
43  2016 Intracoronary Poloxamer 188 Prevents Reperfusion Injury in a Porcine Model of ST-Segment Elevation Myocardial Infarction. PEG, STEMI
44  2016 Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis. BP, CA, HR
45  2016 Spontaneous multi-focal coronary artery spasm: a case report. PCI
46  2016 Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. CMR, LV, MVO, PPCI, SNP, STEMI
47  2016 Ventricular fibrillation with intracoronary adenosine during fractional flow reserve assessment. ECG, FFR, NSTEMI, VF
48  2015 Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. AMI, LV, MSCs, TF
49  2015 Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease. EI, IVUS, PAV, RI, SLV, WSS
50  2015 Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. ACS, LVEF, MACE, PCI, RCTs, TIMI, TMP grade 3, TVR
51  2015 Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis. AMI, CI, HF, LVEF, MBG, MDs, PCI, RRs, STR, TIMI
52  2015 Efficiencies of intracoronary sodium nitroprusside on fractional flow reserve measurement. AD, FFR, SNP
53  2015 Intracoronary Adenosine: Dose-Response Relationship With Hyperemia. LCAs, RCAs
54  2015 Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. IVUS, MACE, MI, OCT, STEMI
55  2015 Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood. PB
56  2015 Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial. AT, IL, PCI, STEMI, TIMI
57  2015 Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. BMCs, DCM, G-CSF, LV, LVEF, NYHA
58  2015 Variability of fractional flow reserve according to the methods of hyperemia induction. ATP, FFR
59  2014 Comparison of the novel vasodilator uridine triphosphate and adenosine for the measurement of fractional flow reserve. FFR, UTP
60  2014 Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome. PPCI
61  2014 Effects of intracoronary sodium nitroprusside compared with adenosine on fractional flow reserve measurement. AD, AVB, FFR, SNP
62  2014 Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. AT, IMR, MVO, PCI, STEMI
63  2014 Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution. AMI, ASCs, CFR, IMR, LAD, RCV
64  2014 Intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. ADN, FFR, IVADN
65  2014 Left main coronary arterial endothelial function and heterogenous segmental epicardial vasomotor reactivity in vivo: novel insights with intravascular ultrasonography. LA, LMCA, PAV
66  2014 ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation. FFR
67  2014 The effect of acute simvastatin administration on the severity of arrhythmias resulting from ischaemia and reperfusion in the canine: Is there a role for nitric oxide? NO, VPBs, VT
68  2013 Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. FFR, IVA, NTP
69  2013 Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function. CFI, ICSO, Pao
70  2013 Fractional flow reserve: intracoronary versus intravenous adenosine induced maximal coronary hyperemia. FFR
71  2013 Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial. GPI, sIRA, STEMI, TIMI
72  2013 Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. mLAD
73  2013 Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials. GPI
74  2013 Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial. CK-MB, cTnI, PCI
75  2013 Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction. CK, IRA, LVEF, MACEs, NR, NTP, PCI, STEMI, STR, TIMI, TMPG
76  2013 Intracoronary Reopro during Percutaneous Coronary Intervention in Acute and Stable Patient can Influence Stent Thrombosis Formation (IRPASST) Study. BMS, DES, ISR, MACE, PCI, ST, TRV, TVR
77  2013 Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis. ACS, CI, i.v, RR
78  2013 Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function. GP, LV, PCI, STEMI
79  2013 Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon. MACE, NR, PCI, TIMI
80  2013 Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. FFR, i.v
81  2013 The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction. AMI, BMSCs, LVEF, PCI
82  2012 A comparison of intracoronary with intravenous glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. ACS, GPIs, LVEF, MACEs, PCI, TIMI, TMPG, TVR
83  2012 Appropriate timing of nitroglycerin prior to intravascular ultrasound. AoP, EEMa, EEMd, IVUS, LA, LD, NTG, sec
84  2012 Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. PCI, STEMI
85  2012 Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials. CI, PPCI, STEMI, TVR
86  2012 Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts. LV, mRNA, NTG
87  2012 Coronary beta2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. IVUS, L-NMMA, PAV
88  2012 Granulation tissue is altered after intramyocardial and intracoronary bone marrow-derived cell transfer for experimental acute myocardial infarction. AMI, BMMC, EF, IM
89  2012 Intracoronary use of GP IIb/IIIa inhibitors in percutaneous coronary interventions. GP, PCI
90  2012 Ischemia-reperfusion increases transfection efficiency of intracoronary adenovirus type 5 in pig heart in situ. TE
91  2012 Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. sTnI
92  2012 Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. ADN, FFR, i.v, IVADN, NTP
93  2012 Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. PPCI
94  2012 Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency. MSC, TE
95  2012 Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. CI, OR, RCTs, re-MI, STEMI, TVR
96  2012 Vasomotor response to different endothelium-dependent vasodilators in an animal model. ---
97  2011 Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. MACEs, MRI, PCI, STEMI
98  2011 Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. BM, ChC, MNC
99  2011 Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year. MI, PPCI, STEMI, TVR, TVR
100  2011 Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial. MI, PPCI, STEMI, TVR